Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Non Operating Income (2020 - 2025)

Historic Non Operating Income for Biofrontera (BFRI) over the last 6 years, with Q3 2025 value amounting to -$365000.0.

  • Biofrontera's Non Operating Income rose 4830.03% to -$365000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $27000.0, marking a year-over-year decrease of 9958.74%. This contributed to the annual value of -$527000.0 for FY2024, which is 12058.59% down from last year.
  • Per Biofrontera's latest filing, its Non Operating Income stood at -$365000.0 for Q3 2025, which was up 4830.03% from -$264000.0 recorded in Q2 2025.
  • Over the past 5 years, Biofrontera's Non Operating Income peaked at $8.7 million during Q1 2022, and registered a low of -$12.9 million during Q4 2021.
  • Over the past 5 years, Biofrontera's median Non Operating Income value was $79000.0 (recorded in 2021), while the average stood at $377736.8.
  • Per our database at Business Quant, Biofrontera's Non Operating Income soared by 1091392.41% in 2022 and then crashed by 26024.21% in 2023.
  • Over the past 5 years, Biofrontera's Non Operating Income (Quarter) stood at -$12.9 million in 2021, then soared by 122.03% to $2.8 million in 2022, then surged by 160.4% to $7.4 million in 2023, then plummeted by 95.76% to $313000.0 in 2024, then crashed by 216.61% to -$365000.0 in 2025.
  • Its Non Operating Income stands at -$365000.0 for Q3 2025, versus -$264000.0 for Q2 2025 and $343000.0 for Q1 2025.